Review
The rosiglitazone meta-analysis
Affiliations
- PMID: 17603430
Item in Clipboard
Review
The rosiglitazone meta-analysis
Rev Cardiovasc Med.
2007 Spring.
Erratum in
- Rev Cardiovasc Med. 2007 Summer;8(3):174
No abstract available
Similar articles
-
The rosigliazone meta-analysis: lessons for the future.Diabetes Care. 2008 Mar;31(3):e10. doi: 10.2337/dc07-2147. Diabetes Care. 2008. PMID: 18308673 No abstract available.
-
Faster publication isn't always better.Nat Clin Pract Cardiovasc Med. 2007 Jul;4(7):345. doi: 10.1038/ncpcardio0942. Nat Clin Pract Cardiovasc Med. 2007. PMID: 17589426 No abstract available.
-
Cardiac safety profile of rosiglitazone: a comprehensive meta-analysis of randomized clinical trials.Int J Cardiol. 2010 Aug 20;143(2):135-40. doi: 10.1016/j.ijcard.2009.01.064. Epub 2009 Mar 27. Int J Cardiol. 2010. PMID: 19328563
-
Thiazolidinediones in type 2 diabetes: a cardiology perspective.Ann Pharmacother. 2008 Oct;42(10):1466-74. doi: 10.1345/aph.1K666. Epub 2008 Sep 2. Ann Pharmacother. 2008. PMID: 18698014 Review.
-
Lessons from the Avandia controversy: a new paradigm for the development of drugs to treat type 2 diabetes.Diabetes Care. 2007 Dec;30(12):3141-4. doi: 10.2337/dc07-1908. Diabetes Care. 2007. PMID: 18042753 Review. No abstract available.
Cited by
-
Rosiglitazone : a review of its use in type 2 diabetes mellitus.Drugs. 2007;67(18):2747-79. doi: 10.2165/00003495-200767180-00008. Drugs. 2007. PMID: 18062722 Review.
-
Rosiglitazone and cardiovascular risk.Curr Atheroscler Rep. 2008 Oct;10(5):398-404. doi: 10.1007/s11883-008-0062-7. Curr Atheroscler Rep. 2008. PMID: 18706281 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical